The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?
- PMID: 19798423
- PMCID: PMC2754866
- DOI: 10.3410/M1-35
The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?
Abstract
Patients with inflammatory rheumatic diseases have an increased risk of cardiovascular disease, raising questions of whether primary prevention strategies that are more aggressive than cardiac risk factor modification alone should be implemented. Recent trials demonstrating the efficacy of statins in reducing rates of cardiovascular events in healthy persons with elevated levels of C-reactive protein broaden the potential protective mechanisms of statins, but do not directly translate to primary cardiovascular disease prevention in patients with inflammatory rheumatic diseases.
Similar articles
-
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.Drug Des Devel Ther. 2010 Dec 9;4:383-413. doi: 10.2147/DDDT.S10812. Drug Des Devel Ther. 2010. PMID: 21267417 Free PMC article. Review.
-
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?Am J Cardiol. 2006 Jan 16;97(2A):33A-41A. doi: 10.1016/j.amjcard.2005.11.014. Epub 2005 Dec 1. Am J Cardiol. 2006. PMID: 16442935 Review.
-
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.Circulation. 2010 Mar 9;121(9):1069-77. doi: 10.1161/CIRCULATIONAHA.109.906479. Epub 2010 Feb 22. Circulation. 2010. PMID: 20176986 Free PMC article. Clinical Trial.
-
JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses.World J Cardiol. 2011 Jul 26;3(7):207-14. doi: 10.4330/wjc.v3.i7.207. World J Cardiol. 2011. PMID: 21860701 Free PMC article.
-
Influence and critique of the JUPITER Trial (Statins v no statins for primary prevention of cardiovascular events in patients with normal lipids and elevated C-reactive protein).Semin Vasc Surg. 2011 Sep;24(3):172-9. doi: 10.1053/j.semvascsurg.2011.10.005. Semin Vasc Surg. 2011. PMID: 22153029 Review.
Cited by
-
Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!F1000 Med Rep. 2010 Apr 12;2:27. doi: 10.3410/M2-27. F1000 Med Rep. 2010. PMID: 20948858 Free PMC article.
References
-
- Han C, Robinson DW, Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis psoriatic arthritis and ankylosing spondylitis. J Rheumatol. 2006;33:2167–72. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials